Come join others currently navigating treatment in our weekly Zoom Meetup! Register here: Tuesdays, 1pm ET.

Breaking Research News from sources other than Breastcancer.org

11112141617107

Comments

  • claireinaz
    claireinaz Member Posts: 714
    edited July 2018

    Ah, I get it now. Arizona has no such warning, but I do know about the hazards of paper receipts from stores (grocery etc) and wash my hands to remove the chems that can cause cancer from those receipts. Whole Foods, I know, uses paper that is safe, but others don't.

    Claire

  • aterry
    aterry Member Posts: 142
    edited July 2018

    Marijen & Claireinaz, the warning exists on products all over the country. I live in NYC. I call it the California warning because it relates to legislation passed in that state and because the warning specifically says, "...known to the state of California to cause cancer and/or birth defects...." The guy at the hardware store said to me, "You don't have to worry about it since this isn't California." I said, "Do you think cancer knows what state you live in?" A neighbor found the warning on a portfolio that she bought for her art work. I think it's widespread.

    And, yes, the products I saw were made in China but I don't know whether manufacturers in the US have eliminated those chemicals from their supply chain.

  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    aterry, great answer. What did the hardware guy say to that

  • Chemokaze
    Chemokaze Member Posts: 177
    edited July 2018

    Oncolytics: Significant Pipeline Value In The Fastest Growing Area Of Oncology

    http://flip.it/IeTS-A


  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    Who are 'You People' Anyway? – National Pain Report


    http://nationalpainreport.com/who-are-you-people-a...


  • illimae
    illimae Member Posts: 5,739
    edited July 2018

    marijen, I think the new part is the additional of Perjeta in early stage treatment. As stage IV HER2+, this combo is standard protocol.

  • minustwo
    minustwo Member Posts: 13,348
    edited July 2018

    I agree. I know some women who had H&P along with neo-adjuvant chemo but still had to fight to get their insurance to pay for Perjeta the rest of the year after surgery.

  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    Oh good, then I'm glad I posted it. Thanks Illimae and MinusTwo. It says 18% more chance of recurrence for HER+ :(

  • illimae
    illimae Member Posts: 5,739
    edited July 2018

    yeah, 18% is not good. HER2 also likes the brain as I and many have discovered. Oh well, we do what we can.

    Thanks for posting all, I read this often but don’t add much.

  • aterry
    aterry Member Posts: 142
    edited July 2018

    Chemokaze, thanks for posting the Siddhartha Mukherjee article. Many times when people learn that I've just been treated for cancer they tell me about anti-cancer diets they've heard about. They are always very intense about these diets and are frustrated if I don't immediately embrace the diet. During my treatment I relied on the nutritionist at the Dubin Breast Center when I wasn't sure how to plan. I think it's great that there will be actual data about a specific approach.

  • mike3121
    mike3121 Member Posts: 280
    edited July 2018

    Something I came across:

    https://medicalxpress.com/news/2018-07-scientists-sharpen-edges-cancer-chemotherapy.html

    My wife is now on Halaven as her Xeloda failed her. She's tolerating it okay. Her ER/PR+ turned triple negative about 1 1/2 years ago and was put on Xeloda.


  • pi-xi
    pi-xi Member Posts: 177
    edited July 2018

    Comparison of Treatment Outcomes with Breast-conserving Surgery plus Radiotherapy versus Mastectomy in Patients with Stage I Breast cancer: A Propensity Score-matched Analysis

    Not that I had a choice in my surgery, but this wasn't a great abstract for me to see first thing in the morning. Good news for others though.


  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    CDC Opioid Restrictions Reading List | EDS and Chronic Pain News & Info - long list of links here


    https://edsinfo.wordpress.com/pain/cdc-opioid-restrictions-reading-list/



  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    Get Ready for the Future!

    Trackable Pill Technology and Smart Bottles

    6 Replies


    https://edsinfo.wordpress.com/2018/07/11/trackable...


  • Chemokaze
    Chemokaze Member Posts: 177
    edited July 2018

    Fighting Cancer With Cancer: Scientists Use CRISPR To Tweak Tumor Cells And Make Them Attack 'Their Own Kind'

    http://flip.it/hq2KKN

    (This article includes METASTATIC BREAST CANCER

  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    That’s funny! I hope it works

  • Lumpie
    Lumpie Member Posts: 1,553
    edited July 2018

    Potential DNA damage from CRISPR has been 'seriously underestimated,' study finds

    https://www.statnews.com/2018/07/16/crispr-potenti...

    Research published on Monday (16 July 2018) suggests that... CRISPR-Cas9 can cause significantly greater genetic havoc than experts thought... perhaps enough to threaten the health of patients who would one day receive CRISPR-based therapy.... Some CRISPR'd cells might be missing a key anti-cancer mechanism ....

  • Lumpie
    Lumpie Member Posts: 1,553
    edited July 2018

    Curing Metastatic Breast Cancer

    http://ascopubs.org/doi/full/10.1200/JOP.2015.0089...

    Metastatic breast cancer is generally considered incurable, and this colors doctor-patient interactions for patients with metastatic disease. Although true for most patients, there appear to be important exceptions, instances where long-term disease-free survival occurs. Although these instances are few in number, they suggest the possibility of cure. How will we move toward cure for a much larger population of patients with metastatic disease? This article outlines a potential research agenda that might move us toward that distant goal.

    {article is from 2016 but interesting}

  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    A very interesting, honest and sobering article Lumpie, thanks for posting. Just as I suspected.



  • minustwo
    minustwo Member Posts: 13,348
    edited July 2018

    Wow Lumpie. Yes, thanks for posting. Since I had what was called a 'recurrence' after BMX, and the type 'mutated' from DCIS to IDC - this article makes sense of a lot of loose ends.

  • heidihill
    heidihill Member Posts: 1,858
    edited July 2018

    Lumpie, thanks for the link. I am a long-term survivor of mets at almost 11 years out. Just eyeballing those stats I will likely make it to 15, even 20.

    "Studies of tumor-infiltrating lymphocytes in the adjuvant setting have suggested that their presence is a powerful predictor of outcome, suggesting that we already rely on the immune system for therapeutic impact even in the absence of immune-based therapies.26"

    This has been the only explanation that made sense to me, although I don't really know if my tumor had a lot of TILs. Given the outcome, it probably did.

    I had neoadjuvant chemo, surgery, radiation and hormonal treatment.

    I put my hopes on this article from 2001 when I started treatment in 2007, Can We Cure Limited Metastatic Breast Cancer? The odds were much lower then.

    http://ascopubs.org/doi/full/10.1200/JCO.2002.20.3.620

  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    Heidihill, that’s great for you! May I ask why you didn’t start Tamoxifen until 2015?



  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    FDA Expands Ribociclib Breast Cancer Approval Under New Pilot Programs

    https://onclive.cmail19.com/t/j-l-ntujruk-jrtrfkdyh-y/


  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    Optimal Duration of Adjuvant Endocrine Therapy Undecided in ER+ Breast Cancer

    Caroline Seymour

    Published: Tuesday, Jul 10, 2018

    Www.onclive.com

    Under breast cance

  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    Optimal Use With Adjuvant Endocrine Therapy Continues to Unfold in ER+ Breast Cancer

    Caroline Seymour

    Published: Monday, Jul 09, 2018

    Excerpt

    "You're treating 20 to 30 patients with a drug for 10 years to help one patient," said Denes. "We have to figure out how to better identify that one patient and let the other patients live happy lives."

    Www.onclive.com


  • marijen
    marijen Member Posts: 2,181
    edited July 2018

    FDA recalls heart drugs made by Teva, others over carcinogen impurity

    By Wallace Witkowski

    Published: July 13, 2018 5:58 p.m. ET


    https://www.marketwatch.com/story/fda-recalls-heart-drugs-made-by-teva-others-over-carcinogen-impurity-2018-07-13


  • KPW3
    KPW3 Member Posts: 127
    edited July 2018

    Antibody-Drug Conjugate Gets Priority Review for Metastatic Triple-Negative Breast Cancer

    https://www.empr.com/drugs-in-the-pipeline/sacituz...



  • KPW3
    KPW3 Member Posts: 127
    edited July 2018

    FDA Approves Additional Breast Cancer Indications for Kisqali

    https://www.empr.com/news/kisqali-ribociclib-preme...


  • heidihill
    heidihill Member Posts: 1,858
    edited July 2018

    marjen, I was on AIs.